Latest information on COVID-19
Support teaching, research, and patient care.
Dr. Bing Melody Zhang is board-certified by American Board of Pathology in Clinical Pathology and Molecular Genetic Pathology. She is also a certified and fully credentialed HLA laboratory director by American Society for Histocompatibility & Immunogenetics (ASHI) for the following areas--Solid Organ Transplantation: Deceased Donor; Solid Organ Transplantation: Live Donor; HSC/BM Transplantation: Related Donor; HSC/BM Transplantation: Unrelated Donor; Histocompatibility Testing for Other Clinical Purposes; Transfusion Support. Dr. Zhang completed Clinical Pathology residency, Molecular Genetic Pathology as well as Clinical Genomics fellowships, and Histocompatibility/Immunogetics training at Stanford. She is an attending pathologist at the molecular pathology service and the assistant director of the HLA lab. Her main research interests include genetic/genomic testing for malignant and non-malignant hematologic disorders, NGS-based TCR/Ig clonality/MRD diagnostic testing, molecular testing for BMT/solid organ transplantation, and HLA-related disease association and pharmacogenetic testing.
My main research interests lie in the following areas: <br/>1) Using genetic/genomic approaches to study the genotype-phenotype correlation of inherited non-malignant hematologic disorders, especially platelet disorders. <br/>2) Development and application of molecular assays for clinical testing to support hematopoietic stem cell transplantation and solid organ transplantation.<br/>3) NGS-based TCR/Ig clonality/MRD diagnostic testing.<br/>4) HLA-related disease association and pharmacogenetic testing.